Biotech and StockMarket Podcast May 31 2016… $IONS $RLYP Gold, Oil + Macros $IONs discussed here on why we took call options. Danny explains the situation there and why it’s not as bad as the market is thinking. We also…
Tag: business
Negative Interest Rates Next Up – Will Pump Markets But Destroy The Global Financial System
Once again, in the September Federal Reserve (FED) policy meeting, the FED did not raise the fed fund rate, leaving it at 0% to 0.25%. The stock market has had a huge run since the lows of 2009. At their…
Free Public Preview Video: Explanation on Current Market Situation Jan.29, 2014
Explanation on Current Market Situation Jan.29, 2014. $SPY reviewed later on in video. Mis-speak, I said “76 Million jobs” I later correct that to the proper “76 thousand jobs” I speak about potential head and shoulders in the charts, as…
Sunshine Heart’s Pulse System Could Revolutionize How Heart Failure Is Treated
Recent developments in the medical device industry have paved the way for some strong achievements in many different sectors of the health care industry. With regards to heart failure, significant developments date back to the first implantable pacemaker successfully inserted…
Trius and General Market Commentary 6/5/13
Trius and General Market Commentary 6/5/13.. Answering critics and explaining market cap to price. Business basics as well.
Weekend update with some charts, Market forecast and opinion. (VIDEO)
Weekend update with some charts, $AVEO $ATRS $ARNA $ACRX briefly covered. Market forecast and opinion. YouTube Video
Significant catalysts and an unfortunate PR mistake present an opportunity in AcelRx Pharmaceuticals.
With The positive result of the first phase III study, coupled with the positive responses of nurses and patients, AcelRx Pharmaceuticals (ACRX) saw a substantial increase in its share price, reaching a high of $5.19 in late November. As is often…
Why the latest rally could be a bull trap
This week has been a strange market week for sure. I have held back on picks mainly because I want to see some clarity as I believe we are at a market top, and economic data has peaked out. Furthermore,…
DARA Poised to Break Out on Catalysts
DARA Biosciences (NASDAQ: DARA) is expecting to hear soon on the status of its Orphan Drug application submitted to The Food and Drug Administration (FDA) in November of last year for its drug KRN5500, which is being studied for the…
Small Cap Biotechs That Could Make Big Moves This Week
Star Scientific (STSI) Star Scientific engages in the manufacture, distribution, and sale of consumer products, dietary supplements, and dissolvable tobacco. They also have several products which have a botanical-based component designed to treat a range of neurological conditions including Alzheimer’s…
